Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: Review of five seasons and evaluation of an electronic reminder

Journal of Hospital Medicine

Volumn 4, Issue 3, 2009, Pages 171-178

  Wilkes, Jennifer J ^a   Zaoutis, Theokis E ^a   Keren, Ron ^b   Desai, Bimal ^b   Leckerman, Kateri H ^a   Hodinka, Richard L ^a   Metjian, Talene A ^a   Coffin, Susan E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Children; Influenza; Oseltamivir

Indexed keywords

AMANTADINE; OSELTAMIVIR; ANTIVIRUS AGENT;

ADULT; AGE DISTRIBUTION; CHILD; COMMUNICABLE DISEASE; DIAGNOSTIC TEST; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MENTAL DISEASE; NEUROLOGIC DISEASE; OFF LABEL DRUG USE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; REMINDER SYSTEM; RETROSPECTIVE STUDY; REVIEW; SEASONAL VARIATION; SEIZURE; SKIN MANIFESTATION; ADOLESCENT; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; HOSPITAL; STATISTICS;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFLUENZA, HUMAN; OSELTAMIVIR; PHYSICIAN'S PRACTICE PATTERNS; REMINDER SYSTEMS; RETROSPECTIVE STUDIES;

EID: 67649366521     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.431     Document Type: Review

References (16)

1. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239.
2. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits and courses of antibiotics in children. N Engl J Med. 2000;342:225-231.
3. Centers for Disease Control and Prevention (CDC). Diseases and Conditions. Seasonal Flu. CDC Health Alert: CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 2005-06 influenza season. January 14, 2006. Available at http://www.cdc.gov/flu/han011406.htm. Accessed November 2008.
4. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001; 20(2):127-133.
5. Shah S, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007; 161(3):282-290.
6. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA. 2005;294:2188-2194.
7. Schrag SJ, Shay DK, Gershman K, et al. Multistate surveillance for laboratory-confirmed influenza-associated hospitalizations in children 2003-2004. Pediatr Infect Dis J. 2006;25(5):395-400.
8. Dominguez SR, Daum RS. Physician knowledge and perspectives regarding influenza and influenza vaccination. Hum Vaccin. 2005;1(2):74-79.
9. Ohmit SE, Monto AS. Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis. 2006;43:564-568.
10. Rothberg MB, Bonner AB, Rajab MH, Kim HS, Stechenberg BW, Rose DN. Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza. Clin Infect Dis. 2006;42:95-99.
11. Moore DL, Vaudry W, Scheifele DW, et al. Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004. Pediatrics. 2006;118:e610-e619.
12. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293:1223-1238.
13. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353(24):2559-2567.
14. Centers for Disease Control and Prevention (CDC). Diseases and Conditions. Seasonal Flu. Flu Activity & Surveillance. Overview of influenza surveillance in the United States. Available at http://www.cdc.gov/flu/weekly/fluactivity.htm. Accessed November 2008.
15. Okumura A, Kubota T, Kato T, Morishima T. Oseltamivir and delirious behavior in children with influenza. Pediatr Infect Dis J. 2006;25(6):572.
16. Edwards ET, Truffa MM, Mosholder AD. Post-Marketing Adverse Event Reports. Review of Central Nervous System/Psychiatric Disorders Associated with the Use of Tamiflu, Drug: Oseltamivir Phosphate. Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology. 2006. OSE PID #D060393 Oseltamivir - Neuropsychiatric Events.